In oral squamous cell carcinoma, genistein selectively induces tumor cell apoptosis by suppressing the PI3K/AKT–EZH2 signaling pathway, underscoring its potential as a targeted therapeutic agent [33]. Here, EZH2 is linked to neoplasm.